(1) Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; (2) Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia

(1) Institute of Neuroscience and Physiology, Section for Clinical Neuroscience and Rehabilitation, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; (2) Department of Anatomy with Radiology, Centre for Brain Research, University of Auckland, Auckland, New Zealand; (3) Australian Centre for Blood Diseases, Department of Clinical Haematology, Alfred Medical Research and Education Precinct, Monash University, Melbourne, Victoria, Australia

(1) UMR 3145 SysDiag CNRS/Bio-Rad, Parc Euromédecine, Montpellier, France; (2) Haemophilia Treatment Centre, Children Hospital la Timone, Mediterranean University, Marseille, France; (3) Haemophilia Treatment Centre, University Hospital of Montpellier, France; (4) Haematology Department, University Hospital La Timone, Marseille, France; (5) Division of Clinical Epidemiology, University Hospital of Geneva and University of Geneva, Switzerland; (6) Haemophilia Treatment Centre, University Hospital of Clermont-Ferrand, France; (7) Haemophilia Treatment Centre, University Hospital of Saint-Etienne, France

(1) Medical Affairs, Sanofi-Aventis (Suisse) SA, Meyrin, Switzerland; (2) Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland; (3) Department of Internal Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; (4) Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland; (5) Department of Internal Medicine, Cantonal Hospital Fribourg, Fribourg, Switzerland; (6) Department of Internal Medicine, University Hospital Basel, Basel, Switzerland; (7) Department of Internal Medicine, Cantonal Hospital Frauenfeld, Frauenfeld, Switzerland; (8) Department of Internal Medicine, Cantonal Hospital Lucerne, Lucerne, Switzerland; (9) Division of General Internal Medicine, University Hospital Bern, Bern, Switzerland

(1) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan

(1) Medizinische Klinik IV, Max-Ratschow-Klinik für Angiologie, Klinikum Darmstadt GmbH, Darmstadt, Germany; (2) Klinikum Friedrichstadt, Dresden, Germany; (3) Institut für Experimentelle Onkologie und Therapieforschung, TU München, Germany; (4) Klinikum Lippe-Detmold, Detmold, Germany; (5) Private practice, T6, 25, 68161 Mannheim, Germany; (6) Novartis Pharma GmbH, Nürnberg, Germany; (7) Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany; (8) Charité, Campus Virchow Klinikum Berlin, Germany

(1) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan

(1) Department of Biochemistry, Queen's University, Kingston, Ontario, Canada; (2) Department of Chemistry and Biochemistry, University of Windsor, Windsor, Ontario, Canada

(1) Department of Cardiology and Angiology, University Hospital Münster, Münster, Germany; (2) Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig-Maximilians-University, Munich, Germany; (3) Institute for Research in Myocardial Infarction Ludwigshafen of the University of Heidelberg, Heidelberg, Germany; (4) University of Bonn, Bonn, Germany; (5) St Vincenz-Hospital Hospital Paderborn, Germany and Department of Clinical Pharmacology, University of Magdeburg Hospital, Magdeburg, Germany; (6) Department of Medical Biometry and Epidemiology, University Hospital, Hamburg-Eppendorf, Germany; (7) Department of Cardiology, University Heart Center Hamburg, Hamburg, Germany; (8) Department of Medicine I, Brandenburg Municipal Hospital, Brandenburg, Germany; (9) Department of Pharmacology and Toxicology, Medical Faculty, Dresden University of Technology, Dresden, Germany

(1) Institut de Cardiologie, INSERM_UMR_937, Pitié-Salpêtrière University Hospital (AP-HP), Université Paris 6, Paris, France; (2) Toulouse Laboratory of Haematology, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC) INSERM 1048, CHU de Toulouse and Université Paul Sabatier, Toulouse, France; (3) University of Toulouse, Rangueil University Hospital, Dept. of Vascular Medicine, Toulouse, France; (4) Department of Epidemiology, Health Economics and Public Health, UMR 558 INSERM, Université de Toulouse, CHU de Toulouse, Toulouse, France

(1) Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China; (2) Vector Biology Section Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA; (3) School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China; (4) Malaria Genetics Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

(1) Thrombosis Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; (2) Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; (3) Puget Sound Blood Center and Hematology Division, University of Washington School of Medicine, Seattle, Washington, USA

(1) The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; (2) Department of Medicine, Stony Brook University, Stony Brook, New York, USA; (3) Medical University of South Carolina, Charleston, South Carolina, USA; (4) University of Pennsylvania, Philadelphia, Pennsylvania, USA

(1) College of Pharmacy, Seoul National University, Seoul, South Korea; (2) Amorepacific Corporation R&D center, Gyeonggi-do, South Korea; (3) Mediplex Corp., Seoul, South Korea; (4) Toxicology Research Center, Korea Research Institute of Chemical Technology, Daejeon, South Korea; (5) WCU Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Pharmacy, Seoul National University, Seoul, South Korea

(1) Institute of Haematology and Transfusion Medicine, Warsaw, Poland; (2) Werlhof Institute, Hannover, Germany

(1) Medical University of Vienna, Vienna, Austria; (2) Hotel Dieu University Hospital, Paris, France; (3) Daiichi Sankyo Co., Ltd., Tokyo, Japan; (4) Daiichi Sankyo Pharma Development, Edison, New Jersey, USA

(1) Kinder- und Jugendklinik, Universitätsklinikum Erlangen, Erlangen, Germany; (2) Transfusionsmedizinische und Hämostaseologische Abteilung, Universitätsklinikum Erlangen, Erlangen, Germany

(1) Department of Epidemiology and Public Health, National University of Singapore, Singapore; (2) Department of Haematology-Oncology, National University Health System, Singapore; (3) Cancer Science Institute of Singapore, Singapore

(1) Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; (2) School of Mathematics and Statistics, Newcastle University, Newcastle upon Tyne, UK; (3) Department of Paediatric Cardiology, The Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK

(1) Wayne State University, Division of Pediatric Hematology Oncology, Carmen and Ann Adams Department of Pediatrics, Children’s Hospital of Michigan, Detroit, Michigan, USA; (2) Royal Children's Hospital, Clinical Haematology, Parkville, Victoria, Australia; (3) University of Alberta, Pediatrics, Edmonton, Alberta, Canada; (4) McMaster University, Division of Pediatric Hematology/Oncology, Hamilton, Ontario, Canada